Roche's Franz Humer - CEO Pay
Franz Humer - Roche
Total Compensation: $11.1M
2007 Revenue: $44.2B
2006 Revenue: $33.5B
Change: 31.9%
Details: Humer's base pay in 2007 was $5.74 million and he earned a $2.86 million bonus. He also earned about $1.75 million in stock an options. 2007 was Humer's last year as Roche's CEO. In a surprise move, Humer handed over the top executive post to Severin Schwan, head of Roche's diagnostics division. Humer remains Chairman of the company.
Roche News:
Schwan takes helm of Roche in surprise move
Roche won't budge on $3 billion Ventana offer
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: